1-3 of 3
Alicia L. Carlson
Close
Sort by
Journal Articles

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy

Abdel Kareem Azab, Judith M. Runnels, Costas Pitsillides, Anne-Sophie Moreau, Feda Azab, Xavier Leleu, Xiaoying Jia, Renee Wright, Beatriz Ospina, Alicia L. Carlson, Clemens Alt, Nicholas Burwick, Aldo M. Roccaro, Hai T. Ngo, Mena Farag, Molly R. Melhem, Antonio Sacco, Nikhil C. Munshi, Teru Hideshima, Barrett J. Rollins, Kenneth C. Anderson, Andrew L. Kung, Charles P. Lin, Irene M. Ghobrial
Journal: Blood
Blood (2009) 113 (18): 4341–4351.
https://doi.org/10.1182/blood-2008-10-186668
Published: 2009
Includes: Supplemental data
Journal Articles

Regulation of the New CXCR7 Receptor in Plasma Cell Dyscrasias.

Anne-Sophie Moreau, MD, Xavier Leleu, MD, Xiaoying Jia, Judith Runnels, PhD, Costas Pitsillides, Alicia L. Carlson, PhD, Hai T. Ngo, Aldo M. Roccaro, MD, Abdelkareem Azab, PhD, Feda Azab, Charles P. Lin, PhD, Irene M. Ghobrial, MD
Journal: Blood
Blood (2007) 110 (11): 3527.
https://doi.org/10.1182/blood.V110.11.3527.3527
Published: 2007
Journal Articles

In Vivo Mobilization of Multiple Myeloma Cells Out of the Bone Marrow Using the CXCR4 Inhibitor AMD3100 and Bortezomib: Implications for Sensitization of Myeloma Cells to Apoptosis.

Judith M. Runnels, Abdelkareem Azab, Costas Pitsillides, Anne-Sophie Moreau, Feda Azab, Joel A. Spencer, Xavier Leleu, Alicia L. Carlson, Beatriz E. Ospina, Renee Wright, Xiaoying Jia, Hai Ngo, Andrew L. Kung, Charles P. Lin, Irene M. Ghobrial
Journal: Blood
Blood (2007) 110 (11): 2501.
https://doi.org/10.1182/blood.V110.11.2501.2501
Published: 2007